Chemical Structure : DRI-C21095
Catalog No.: PC-23563Not For Human Use, Lab Use Only.
DRI-C21095 is a specific small molecule inhibitor of CD40-CD40L costimulatory interaction with IC50 of 0.17 uM in cell-free in vitro binding inhibition assay.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
DRI-C21095 is a specific small molecule inhibitor of CD40-CD40L costimulatory interaction with IC50 of 0.17 uM in cell-free in vitro binding inhibition assay.
DRI-C21095 displays no activity against TNF-R1–TNF-α interaction.
DRI-C21095 concentration-dependently inhibits CD40L-induced marker expression (CD54, CD86, CD80, MHC-II) in THP cells
DRI-C21095 exhibits concentration-dependent inhibition of CD40L-induced human B-cell function with IC50 of 4.5 uM.
DRI-C21095 concentration-dependently inhibits CD40L-induced B cell proliferation.
DRI-C21095 (30 mg/kg; daily, s.c. in 20% HPβCD) exhibits prolongation of skin allograft in C57BL6 mice, inhibits alloantigen-induced T cell response in a draining lymph node.
M.Wt | 656.71 | |
Formula | C38H28N2O7S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Chen J, et al. J Med Chem. (2017) 60:8906–22.
2. Bojadzic D, et al. Molecules. (2018) 23:1153.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright